IGC Pharma Launches 12-Part Media Campaign with 4.45M Reach and Times Square Billboards
IGC Pharma has launched a 12-part national media partnership with New to The Street featuring long-form interviews on Fox Business and Bloomberg Television plus Times Square and Financial District billboards. The multimedia campaign will digitally amplify content to over 4.45 million YouTube subscribers and leverage national TV and outdoor placements.
1. Strategic Media Partnership
IGC Pharma's strategic alliance with New to The Street comprises 12 coordinated segments designed to raise investor awareness. This initiative marks the company's first multi-channel media campaign focusing on both national television distribution and targeted outdoor advertising.
2. Campaign Elements
The campaign schedule includes long-form televised interviews, national commercials, and digital amplification reaching a combined audience of over 4.45 million YouTube subscribers. High-visibility outdoor placements in Times Square and the New York City Financial District will further reinforce brand presence among finance professionals.
3. Company Background
IGC Pharma is a clinical-stage biotechnology firm developing AI-driven therapeutics for Alzheimer's disease and metabolic disorders. Its lead asset, IGC-AD1, is in a Phase 2 trial targeting agitation in Alzheimer's dementia, supported by a pipeline addressing amyloid plaques, tau proteins, and neurodegeneration.